Flunitrazepam
- Molecular formula
- C16H12FN3O3
- CAS Number
- 1622-62-4
- IUPAC Name
- 5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one
- Molecular Weight
- 313.27g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.5550g/cm3
- Synonyms
- flunitrazepam
Identification
Interesting Facts about 5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one
The compound known as 5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one is an intriguing member of the benzodiazepine family, which is well-regarded for its pharmacological significance. Here are some compelling aspects of this compound:
- Pharmacological Role: This compound exhibits potential activity as a central nervous system depressant, similar to other benzodiazepines. It plays a crucial role in the management of anxiety and seizure disorders.
- Research Implications: The presence of a fluorine atom, specifically in the 2-position of the phenyl ring, can impact the compound's biological properties, enhancing its potency and selectivity.
- Synthetic Pathways: The synthesis of this compound can involve multi-step organic reactions, providing a fascinating study of chemical transformations and reaction mechanisms.
- Chemical Structure: The unique structure of this molecule, characterized by its nitro group, offers diverse interaction capabilities with biological targets, making it a point of interest for medicinal chemists.
- Potential Applications: Beyond its anticipated medicinal uses, compounds like this are often leveraged in drug design to develop new therapies for neuropsychiatric disorders.
- Complementary Research: Ongoing studies may involve structural modification of the compound to enhance desired therapeutic effects while reducing side effects.
In conclusion, the exploration of 5-(2-fluorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one not only deepens our understanding of benzodiazepines but also prompts new inquiries into how slight modifications can lead to substantial changes in a compound's efficacy and safety profile. As Nobel laureate Richard Feynman aptly stated, "What I cannot create, I do not understand," reminding us of the potent interplay between chemistry and biology in drug development.